Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biomaterials

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biomaterials.2014.02.003PMID 24565517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA

  2013cited by this paper
• Functional diversification of Argonautes in nematodes: an expanding universe

  2013cited by this paper
• Exosomes are natural carriers of exogenous siRNA to human cells in vitro

  2013cited by this paper
• Microvesicle-mediated Transfer of MicroRNA-150 from Monocytes to Endothelial Cells Promotes Angiogenesis*

  2013cited by this paper
• Blockade of Autocrine TGF-β Signaling Inhibits Stem Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer Cells.

  2012cited by this paper
• Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles

  2012cited by this paper
• A membrane vesicle-based dual vaccine against melanoma and Lewis lung carcinoma.

  2012cited by this paper
• Exosome-mediated delivery of siRNA in vitro and in vivo

  2012cited by this paper
• Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes

  2012cited by this paper
• Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

  2011cited by this paper
• SiRNA delivery with exosome nanoparticles

  2011cited by this paper
• Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

  2011cited by this paper
• Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA

  2011cited by this paper
• Nanomaterials: Applications in Cancer Imaging and Therapy

  2011cited by this paper
• Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.

  2010cited by this paper
• Nanomedicine based approaches for the delivery of siRNA in cancer

  2010influential reference
• Secreted monocytic miR-150 enhances targeted endothelial cell migration.

  2010cited by this paper
• Targeting the transforming growth factor-β signaling pathway in human cancer

  2010cited by this paper
• Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis*

  2010influential reference
• The role of cell-released microvesicles in the intercellular transfer of magnetic nanoparticles in the monocyte/macrophage system.

  2010cited by this paper
• Biological gene delivery vehicles: beyond viral vectors.

  2009cited by this paper
• Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

  2009cited by this paper
• A three-dimensional view of the molecular machinery of RNA interference

  2009cited by this paper
• The promises and pitfalls of RNA-interference-based therapeutics

  2009cited by this paper
• Shedding microvesicles: artefacts no more.

  2009cited by this paper
• Axin determines cell fate by controlling the p53 activation threshold after DNA damage

  2009influential reference
• Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity

  2009cited by this paper
• Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

  2008cited by this paper
• Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers

  2008cited by this paper
• Argonaute proteins: key players in RNA silencing

  2008cited by this paper
• Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

  2008cited by this paper
• Silencing of Transforming Growth Factor-β1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo

  2008cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper
• A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.

  2007cited by this paper
• A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

  2007cited by this paper
• Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy

  2007cited by this paper
• Inhibition of TGFbeta signaling in cancer therapy.

  2006cited by this paper
• Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes

  2006cited by this paper
• Transforming growth factor-beta regulation of immune responses.

  2006cited by this paper
• Inhibition of TGFβ signaling in cancer therapy

  2006cited by this paper
• Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

  2002cited by this paper
• Exosomes: composition, biogenesis and function

  2002cited by this paper
• Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

  2002cited by this paper
• TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

  1998cited by this paper
• TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

  1998cited by this paper

• Extracellular vesicles in viral disease management

  2025cites this paper
• Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

  2025cites this paper
• A scalable filtration-based method for isolating exomeres and other nanoscale extracellular particles

  2025cites this paper
• Synthetic and biological nanoparticles for cancer immunotherapy.

  2024cites this paper
• Bioinspired and bioengineered nucleic acid drug carriers

  2024cites this paper
• Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy

  2024cites this paper
• Accessible and Effective Nanomedicines: Self‐Assembly Products From Chinese Herbal Medicines (CHMs)

  2024cites this paper
• Therapeutic potential of RNA-enriched Extracellular Vesicles 1: The next generation in RNA delivery via biogenic nanoparticles.

  2024cites this paper
• Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics

  2024cites this paper
• A Meta-analysis on the Effectiveness of Extracellular Vesicles as Nanosystems for Targeted Delivery of Anticancer Drugs.

  2023cites this paper
• Standardization Approaches for Extracellular Vesicle Loading with Oligonucleotides and Biologics.

  2023cites this paper
• Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes

  2023cites this paper
• Extracellular vesicle–based drug delivery in cancer immunotherapy

  2023cites this paper
• Biomimetic Nanovesicles—Sources, Design, Production Methods, and Applications

  2022cites this paper
• Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications

  2022cites this paper
• Non-viral vectors for RNA delivery

  2022cites this paper
• Decoy Exosomes Offer Protection Against Chemotherapy‐Induced Toxicity (Adv. Sci. 32/2022)

  2022cites this paper
• Exosomal and Non-Exosomal MicroRNAs: New Kids on the Block for Cancer Therapy

  2022cites this paper
• Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications

  2022cites this paper
• Exosomes as Delivery Systems for Targeted Tumour Therapy: A Systematic Review and Meta-analysis of In vitro Studies.

  2022cites this paper
• Suspension state and shear stress enhance breast tumor cells EMT through YAP by microRNA-29b

  2021cites this paper
• Converting Extracellular Vesicles into Nanomedicine: Loading and Unloading of Cargo

  2021cites this paper
• Salivary Biomarkers for Non-invasive Early Detection of Head and Neck Cancer

  2021cites this paper
• Nucleic acid delivery with extracellular vesicles.

  2021cites this paper
• Insight Into the Prospects for RNAi Therapy of Cancer

  2021cites this paper
• Exosomes: A new frontier under the spotlight for diagnosis and treatment of gastrointestinal diseases

  2021cites this paper
• Extracellular Vesicles for Intracellular Drug Delivery

  2021cites this paper
• Extracellular vesicles as a drug delivery system:A systematic review of preclinical studies.

  2021cites this paper
• Low-Molecular-Weight Poly(ethylenimine) Nanogels Loaded with Ultrasmall Iron Oxide Nanoparticles for T1-Weighted MR Imaging-Guided Gene Therapy of Sarcoma.

  2021cites this paper
• Technological advances towards extracellular vesicles mass production.

  2021cites this paper
• Molecular mechanisms underpinning sarcomas and implications for current and future therapy

  2021cites this paper
• Exosomal Dna Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits In A Mouse Parkinson'S Disease Model

  2021cites this paper
• Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles

  2021cites this paper
• Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

  2021cites this paper
• Cross-kingdom regulation by dietary plant miRNAs: an evidence-based review with recent updates.

  2021cites this paper
• Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy

  2020cites this paper
• Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery

  2020cites this paper
• Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes

  2020cites this paper
• Extracellular Vesicle-Mediated Nucleic Acid Transfer And Reprogramming In The Tumor Microenvironment.

  2020cites this paper
• Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC)

  2020cites this paper
• Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies

  2020cites this paper
• Microenvironment‐induced TIMP2 loss by cancer‐secreted exosomal miR‐4443 promotes liver metastasis of breast cancer

  2020cites this paper
• MSC-exosomes in regenerative medicine

  2020cites this paper
• Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.

  2019cites this paper
• Therapy resistance mediated by exosomes

  2019cites this paper
• Microglia-Derived Microvesicles Affect Microglia Phenotype in Glioma

  2019cites this paper
• Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson’s Disease Model

  2019cites this paper
• Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles—A Novel Strategy for Enhancement of the Anti-tumor Immune Response

  2019cites this paper
• Engineering megakaryocytic microparticles for nucleic acid delivery and their biological effects to hematopoietic stem/progenitor cells

  2019cites this paper
• Stable tRNA halves can be sorted into extracellular vesicles and delivered to recipient cells in a concentration-dependent manner

  2019cites this paper
• Advances in delivery vectors for gene therapy in liver cancer.

  2019cites this paper
• Extracellular vesicles: exosomes, microparticles, their parts, and their targets to enable their biomanufacturing and clinical applications.

  2019cites this paper
• Standardized human bone marrow-derived stem cells infusion improves survival and recovery in a rat model of spinal cord injury.

  2019cites this paper
• Extracellular microRNAs initiate immunostimulation via activating toll-like receptor signaling pathways

  2019cites this paper
• Hepatocytes derived extracellular vesicles from high-fat diet induced obese mice modulate genes expression and proliferation of islet β cells.

  2019cites this paper
• Exosomes: A Paradigm in Drug Development against Cancer and Infectious Diseases

  2018cites this paper
• Engineering human megakaryocytic microparticles for targeted delivery of nucleic acids to hematopoietic stem and progenitor cells

  2018cites this paper
• Exosomes: natural nanoparticles as bio shuttles for RNAi delivery

  2018cites this paper
• Extracellular RNAs: A New Awareness of Old Perspectives.

  2018cites this paper
• Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma

  2018cites this paper
• Methotrexate-Loaded Extracellular Vesicles Functionalized with Therapeutic and Targeted Peptides for the Treatment of Glioblastoma Multiforme.

  2018cites this paper
• Microvesicles Released from Human Red Blood Cells: Properties and Potential Applications

  2017cites this paper
• Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.

  2017cites this paper
• Therapeutic targeting strategies using endogenous cells and proteins

  2017cites this paper
• Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy

  2017cites this paper
• The effects of indoxyl sulfate-induced endothelial microparticles on neointimal hyperplasia formation in an ex vivo model

  2017cites this paper
• Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

  2017cites this paper
• New Insight into Inter-kingdom Communication: Horizontal Transfer of Mobile Small RNAs

  2017cites this paper
• Role of exosomes in treatment of hepatocellular carcinoma.

  2017cites this paper
• miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer

  2017cites this paper
• Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities

  2017cites this paper
• Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.

  2017cites this paper
• Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics

  2017cites this paper
• Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy.

  2017cites this paper
• Preparation and Isolation of siRNA-Loaded Extracellular Vesicles.

  2017cites this paper
• Exosome-based small RNA delivery: Progress and prospects

  2017cites this paper
• Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors.

  2017cites this paper
• Ultrasmall Magnetically Engineered Ag2Se Quantum Dots for Instant Efficient Labeling and Whole-Body High-Resolution Multimodal Real-Time Tracking of Cell-Derived Microvesicles.

  2016cites this paper
• Exosome‐mediated small RNA delivery for gene therapy

  2016cites this paper
• The implications of multipotent mesenchymal stromal cells in tumor biology and therapy

  2016cites this paper
• Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

  2016cites this paper
• Therapeutic and diagnostic applications of extracellular vesicles.

  2016cites this paper
• Adipocyte-derived microvesicles from obese mice induce M1 macrophage phenotype through secreted miR-155.

  2016cites this paper
• Microvesicles in Autoimmune Diseases.

  2016cites this paper
• A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells.

  2016cites this paper
• The emerging roles of exosomes in tumor–stroma interaction

  2016cites this paper
• Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease

  2016cites this paper
• Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.

  2016cites this paper
• Extracellular vesicles for drug delivery.

  2016cites this paper
• The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma

  2016cites this paper
• Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery.

  2015cites this paper
• Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery.

  2015cites this paper
• Proteomic signatures of extracellular vesicles secreted by nonmineralizing and mineralizing human osteoblasts and stimulation of tumor cell growth

  2015cites this paper
• Small non-coding RNAs transfer through mammalian placenta and directly regulate fetal gene expression

  2015cites this paper
• Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.

  2015cites this paper
• Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.

  2015cites this paper
• Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse

  2015cites this paper
• Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

  2015cites this paper
• Inflamed macrophage microvesicles induce insulin resistance in human adipocytes

  2015cites this paper
• Exosomes in cancer: small particle, big player

  2015cites this paper